Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants

David M Fleischer1, Scott Sicherer2, Matthew Greenhawt3

  • 1American Academy of Allergy, Asthma & Immunology (AAAAI), Milwaukee, WI United States of America.

Insights

Introducing peanuts early in infancy, during complementary feeding, may offer benefits for allergy prevention. This interim guidance reflects a consensus among leading allergy and pediatric organizations worldwide.

Area of Science:

  • Pediatric Allergy and Immunology
  • Infant Nutrition and Allergy Prevention
  • Food Allergy Research

Background:

  • Existing guidelines on infant feeding practices are evolving.
  • Emerging evidence suggests a shift in recommendations for early allergen introduction.
  • Concerns about food allergies in infants necessitate updated guidance.

Purpose of the Study:

  • To highlight emerging evidence on early peanut introduction in infants.
  • To provide interim guidance on complementary feeding and allergy risk.
  • To inform healthcare professionals and parents about potential benefits of early peanut exposure.

Main Methods:

  • Consensus statement based on emerging scientific evidence.
  • Review of current understanding of infant allergy development.
  • Collaboration among multiple international allergy and pediatric organizations.

Main Results:

  • Early introduction of peanut during complementary feeding may be beneficial.
  • Delayed introduction might not be optimal for allergy prevention.
  • This guidance is based on a consensus of expert opinion.

Conclusions:

  • Interim guidance supports early peanut introduction for infants.
  • Further formal guidelines are anticipated from major research groups.
  • This approach aims to mitigate the risk of developing peanut allergy.

Related Concept Videos

Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
182
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Allergic Reactions02:06

Allergic Reactions

Overview
33.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
201
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K